1. Home
  2. NA vs TVGN Comparison

NA vs TVGN Comparison

Compare NA & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NA

Nano Labs Ltd

HOLD

Current Price

$2.05

Market Cap

58.5M

Sector

Technology

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$5.40

Market Cap

63.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NA
TVGN
Founded
2019
2020
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Blank Checks
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
58.5M
63.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NA
TVGN
Price
$2.05
$5.40
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
69.8K
18.7K
Earning Date
03-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$0.14
52 Week High
$9.22
$12.03

Technical Indicators

Market Signals
Indicator
NA
TVGN
Relative Strength Index (RSI) 51.12 33.86
Support Level $1.62 $0.34
Resistance Level $3.40 $5.64
Average True Range (ATR) 0.17 0.92
MACD 0.03 -0.35
Stochastic Oscillator 69.42 2.96

Price Performance

Historical Comparison
NA
TVGN

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: